Brookline Capital Acquisition Corp II

Brookline Capital Acquisition Corp II (Nasdaq: BCAC) is a blank-check company sponsored by Brookline Capital Markets LLC, a registered broker-dealer with experience advising life sciences and healthcare companies. The SPAC filed an S-1/A amendment with the Securities and Exchange Commission on February 23, 2026, under accession number 0001213900-26-019323, indicating it was in the late stages of registering its initial public offering and had not yet completed pricing as of that date. The vehicle targets acquisition opportunities in the healthcare and life sciences sectors, consistent with the sponsor's advisory focus. For full filing details, deal terms, and real-time status updates on BCAC and hundreds of other active SPACs, sign up for a SpacDesk account at spacdesk.com.